Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.52 |
| ▸ | PPARA | Q07869 | 6/20 | 0.52 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6171187 | 1.00 | PPARG (0.52) | PPARGPPARACYP24A1BLMTSHR | |
| SCHEMBL4224537 | 0.85 | SMN1; SMN2 (0.49) | PPARGPPARACYP24A1ACE | |
| SCHEMBL18063399 | 0.84 | BLM (0.61) | PPARGPPARABLMSRR | |
| SCHEMBL6903818 | 0.84 | PPARG (0.52) | PPARGPPARABLMSRRACE | |
| SCHEMBL6438045 | 0.83 | SRR (0.59) | PPARGPPARASRRACE | |
| SCHEMBL6438277 | 0.83 | SRR (0.59) | PPARGPPARASRRACE | |
| SCHEMBL6907074 | 0.83 | PPARG (0.49) | PPARGPPARABLMTSHRACE | |
| SCHEMBL6903829 | 0.83 | PPARG (0.49) | PPARGPPARABLMTSHRSRR | |
| SCHEMBL7495011 | 0.83 | PPARG (0.61) | PPARGPPARATSHRSRRACE | |
| SCHEMBL27130395 | 0.82 | HTT (0.42) | PPARGPPARATSHRSRR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2005281246-A | METHOD FOR PRODUCTION OF CILAZAPRIL | KONICA MINOLTA CHEMICAL CO LTD | 2005-10-13 | — | — | JP | disclosed |
| EP-1098885-B9 | IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2005-05-18 | — | — | EP | disclosed |
| EP-1098885-B1 | IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-11-17 | — | — | EP | disclosed |
| US-6359145-B1 | ADENOSINE DEAMINASE INHIBITOR; ANTIINFLAMMATORY AGENTS; IMMUNOSUPPRESSANT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |
| EP-1098885-A1 | IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-16 | — | — | EP | disclosed |
| WO-2001026605-A2 | IMMUNOSUPPRESSIVE COMPOSITION CONTAINING IL-2 INHIBITOR AND AN ADENOSINE DEAMINASE INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-19 | — | — | WO | disclosed |
| WO-2000005217-A1 | IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-02-03 | — | — | WO | disclosed |
| EP-0657446-B1 | Process for producing optically active erythro-3-amino-1,2-epoxy compound | NIPPON KAYAKU KK (JP) | 1998-05-13 | — | — | EP | disclosed |
| US-5488118-A | Process for producing optically active erythro-3-amino-1,2-epoxy compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1996-01-30 | — | — | US | disclosed |
| EP-0657446-A1 | Process for producing optically active erythro-3-amino-1,2-epoxy compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1995-06-14 | — | — | EP | disclosed |